TFS TRIAL FORM SUPPORT ApS: Financial statements 2015
CVR: 10064627
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
TFS TRIAL FORM SUPPORT ApS (CVR 10064627) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 14,818,161 and a net result of DKK 463,434 compared with DKK -544,624 the year before. That is an increase of 4.8% compared with the year before. Equity in the 2015 report amounted to DKK 4,895,836. The solvency ratio was 63.8%.
- Gross Profit
- DKK 14,818,161
- Profit/Loss
- DKK 463,434
- Equity
- DKK 4,895,836
- Total Assets
- DKK 7,671,554
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 14.8 mio. | 463 t. | 4.9 mio. | - |
| 2014 | - | 14.1 mio. | -545 t. | 4.4 mio. | - |
| 2013 | - | 14.7 mio. | 330 t. | 5 mio. | - |
| 2012 | - | 12.3 mio. | - | - | - |
Official annual report
How creditworthy is TFS TRIAL FORM SUPPORT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of December 22, 2015, Ryan Shortreed has joined the board of directors of TFS TRIAL FORM SUPPORT ApS.
As of December 22, 2015, Jan Gunnar Hellqvist has left the board of directors of TFS TRIAL FORM SUPPORT ApS.
As of December 22, 2015, János Filakovský is registered as adm. dir. of TFS TRIAL FORM SUPPORT ApS.
As of December 22, 2015, Tina Thuesen has stepped down as director of TFS TRIAL FORM SUPPORT ApS.
As of December 22, 2015, is registered as an owner of TFS TRIAL FORM SUPPORT ApS with an ownership share of 100%.
TFS TRIAL FORM SUPPORT ApS has published its annual report for 2014. Gross profit came to DKK 14,145,008, and the net result was DKK -544,624.
About TFS TRIAL FORM SUPPORT ApS
TFS TRIAL FORM SUPPORT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2001. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jan Markus Granlund. The board consists of Jesper Hjort (chair) and Jan Markus Granlund. The company is owned by TFS International Clinical Development Services AB. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 8,921,130 and a net result of DKK -845,854 compared with DKK -1,834,180 the year before. Equity in the 2025 report amounted to DKK 1,750,487.